AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 71 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,718 | -94.2% | 2,860 | -50.0% | 0.00% | -100.0% |
Q2 2023 | $29,859 | +4.5% | 5,720 | +100.0% | 0.00% | 0.0% |
Q1 2023 | $28,571 | +98420.7% | 2,860 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $29 | -99.9% | 2,860 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $29,000 | 0.0% | 2,860 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $29,000 | -50.8% | 2,860 | -51.0% | 0.00% | 0.0% |
Q1 2022 | $59,000 | +321.4% | 5,840 | +96.0% | 0.00% | – |
Q4 2021 | $14,000 | -41.7% | 2,980 | 0.0% | 0.00% | – |
Q3 2021 | $24,000 | -11.1% | 2,980 | -25.1% | 0.00% | -100.0% |
Q2 2021 | $27,000 | -3.6% | 3,980 | +14.4% | 0.00% | 0.0% |
Q1 2021 | $28,000 | +40.0% | 3,480 | +40.3% | 0.00% | 0.0% |
Q4 2020 | $20,000 | +11.1% | 2,480 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $18,000 | -21.7% | 2,480 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $23,000 | +43.8% | 2,480 | -16.8% | 0.00% | 0.0% |
Q1 2020 | $16,000 | -20.0% | 2,980 | +20.2% | 0.00% | 0.0% |
Q4 2019 | $20,000 | +5.3% | 2,480 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $19,000 | +1800.0% | 2,480 | +1966.7% | 0.00% | – |
Q4 2018 | $1,000 | -80.0% | 120 | -76.0% | 0.00% | – |
Q2 2018 | $5,000 | +66.7% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2017 | $3,000 | -78.6% | 500 | -82.5% | 0.00% | -100.0% |
Q3 2017 | $14,000 | +27.3% | 2,860 | 0.0% | 0.00% | – |
Q2 2017 | $11,000 | -47.6% | 2,860 | 0.0% | 0.00% | -100.0% |
Q1 2017 | $21,000 | +75.0% | 2,860 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $12,000 | -33.3% | 2,860 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $18,000 | – | 2,860 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |